Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 28;11(7):ofae349.
doi: 10.1093/ofid/ofae349. eCollection 2024 Jul.

Hospital Burden of All-Cause Pneumonia and Nonbacteremic Pneumococcal Pneumonia in Adults in France Between 2013 and 2019

Affiliations

Hospital Burden of All-Cause Pneumonia and Nonbacteremic Pneumococcal Pneumonia in Adults in France Between 2013 and 2019

Ayman Sabra et al. Open Forum Infect Dis. .

Abstract

Background: Community-acquired pneumonia (CAP) is associated with significant morbidity and mortality. The study objective was to describe the hospital burden of pneumonia in the adult population in France.

Methods: This retrospective study was conducted from the National Health Insurance Database. All hospitalizations for pneumonia (all-cause) between 2013 and 2019 were included. Different risk categories for patients were established based on pneumococcal vaccine recommendations by French health authorities.

Results: A total of 2 199 240 episodes of CAP were registered over the study period (annual mean, 314 177 [standard deviation, 17 818.6]); 75% occurred in patients aged ≥65 years, among whom 47% were not classified in the moderate- or high-risk categories recommended for French pneumococcal vaccination. The incidence of CAP increased with age (117.9, 395.3, and 1916.7 per 100 000 for the age groups 18-49, 50-64, and ≥65 years, respectively, in 2019). Furthermore, being at risk of pneumococcal disease resulted in more severe outcomes, including longer episode duration (mean, 14 days in low-risk vs 17 days in high-risk patients) and higher risk of referral to critical care units (from 20% to 27%), of rehospitalization up to 180 days (from 39% to 67%), of in-hospital death (from 12% to 19%), and of 1-year mortality (from 26% to 49%).

Conclusions: This study establishes the incidence of CAP in adults in France, describes the significant burden of disease, and highlights the need for better prevention policies.

Keywords: France; Streptococcus pneumoniae vaccination; mortality; pneumococcal disease; pneumonia.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. A. S., M. B., E. B., S. F., J. M., and G. G. are employees of Pfizer. L. W. has received consulting fees from Pfizer for this work and from HEVA and IQVIA, outside the submitted work. A. A., J. T., M. L., N. C., and Y. B. are IQVIA employees, a company which was paid by Pfizer for this work, including manuscript development. M. S. F. reports grants from La Fondation du Souffle, and personal fees from Fisher & Paykel and bioMérieux, outside the submitted work. M. S. F. reports consulting fees from Pfizer for this work.

Figures

Figure 1.
Figure 1.
Prioritization of invasive pneumococcal infections. *Other invasive infections: arthritis, osteomyelitis, endocarditis, and nonrheumatic aortic valve disease (further detailed in Supplementary Table 2). Episodes of other infection were excluded from the analysis. Abbreviation: PD, pneumococcal disease.
Figure 2.
Figure 2.
Incidence rate (per 1 000 000 inhabitants) of hospitalization episodes of all-cause pneumonia, by age and risk group in 2019 in France. Incidence rates were adjusted to account for hospitalization episodes ending in 2020.

References

    1. Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014; 1:ofu024. - PMC - PubMed
    1. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 2013; 68:1057–65. - PMC - PubMed
    1. Said MA, Johnson HL, Nonyane BAS, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013; 8:e60273. - PMC - PubMed
    1. Lansbury L, Lim B, McKeever TM, Lawrence H, Lim WS. Non-invasive pneumococcal pneumonia due to vaccine serotypes: a systematic review and meta-analysis. EClinicalMedicine 2022; 44:101271. - PMC - PubMed
    1. Pick H, Daniel P, Rodrigo C, et al. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013–18. Thorax 2020; 75:38–49. - PubMed